You are here:
Home
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers
Selinexor with pomalidomide and dexamethasone for treating relapsed or refractory multiple myeloma after 1 to 4 treatment lines in people who have not had pomalidomide [ID6705]
Awaiting development
Reference number:
GID-TA11938
Expected publication date: TBC
Project information
Project documents
Documents
Documents created during the development process.
Topic prioritisation
Topic prioritisation
Back to top